2024 Japan Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities
This new report from LeadingMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including:
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
More Publications
2019 Japan Tumor Marker Testing Market: Supplier Shares by Test, and Market Segment Sales Forecasts
US$ 950.00
May 2019
23 pages
Japan Clinical Chemistry and Immunodiagnostic Markets, 2019-2023: Sales and Market Shares of Major Reagent and Instrument Suppliers
US$ 2,250.00
July 2019
73 pages
Japan Hepatitis Molecular and Immunodiagnostics Market, 2019-2023: Supplier Shares and Strategies, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals
US$ 2,850.00
July 2019
241 pages